Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

CRISPR Therapeutics AG (CRSP) closed at $43.42 in the latest trading session, marking a -1.83% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.29%.

About Page PAGE Therapeutics AG ('Page') is a Swiss preclinical-stage biotech company spun out of the ETHZ and founded on the groundbreaking science of Prof. Nicola Aceto. Page targets the ...

Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options become available today, for the March 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

A Google parent-owned startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end, marking a significant milestone in pharmaceutical development as ...

It is a settled right in our Constitution and recognized by the Supreme Court for more than a century,” AG Campbell said. “President Trump does not have the authority to take away ...

WASHINGTON – Wisconsin Attorney General Josh Kaul joined 17 other states in suing President Donald Trump on Tuesday to block an executive order that ends birthright citizenship, setting up an ...

“Valuations are at multi-decade lows.” He further points to companies such as Crispr Therapeutics AG CRSP-Q that use CRISPR (clustered regularly interspaced short palindromic repeats) gene ...

In the clip, which was posted on Friday via X, a celebratory Garland walked and thanked cheering department staffers while the outgoing AG exited out of the building. But, in response, prominent ...